Pancreatic Cancer Research

ResearcherNational Taiwan UniversityNo recent work listed

Kai‐Wen Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6375-8714; OpenAlex author ID A5100432847. Sources: ClinicalTrials.gov.

Their work

Papers
7 (first author 3, last author 1)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2012: 1 trial · 2013: none · 2014: none · 2015: none · 2016: 2 papers, 2 trials · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper

Papers 7

  1. Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1663_20↗
  2. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia. First author DOI 10.1016/j.ejso.2019.12.006↗
  3. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from … Co-author DOI 10.1016/j.hpb.2018.12.004↗
  4. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. First author DOI 10.1016/j.omtn.2019.08.017↗
  5. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.25110↗
  6. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery. Last author DOI 10.1002/jso.24404↗
  7. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo. First author DOI 10.1038/mt.2016.60↗

Trials 3

  1. Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Principal investigator NCT02841800↗
  2. Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors Principal investigator NCT02882503↗
  3. A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer Principal investigator NCT02841436↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Po‐Chih Yang · 2 shared papers, 2018–2020 · strength 0.21
  2. Uei Pua · 2 shared papers, 2018–2020 · strength 0.21
  3. Po‐Chin Liang · 2 shared papers, 2018–2020 · strength 0.21
  4. Robert C.G. Martin · 2 shared papers, 2016–2019 · strength 0.17
  5. Sorah Yoon · 2 shared papers, 2016–2019 · strength 0.15
  6. Nagy Adley Habib · 2 shared papers, 2016–2019 · strength 0.15
  7. John J. Rossi · 2 shared papers, 2016–2019 · strength 0.15
  8. Shengping Li · 1 shared paper, 2020 · strength 0.13
  9. Man Deuk Kim · 1 shared paper, 2020 · strength 0.13
  10. Xiaoyong Li · 1 shared paper, 2020 · strength 0.13
  11. Michelle M. Holland · 1 shared paper, 2019 · strength 0.10
  12. Neal Bhutiani · 1 shared paper, 2019 · strength 0.10
  13. John D. Christein · 1 shared paper, 2019 · strength 0.10
  14. Matthew John Weiss · 1 shared paper, 2019 · strength 0.10
  15. Rebekah Ruth White · 1 shared paper, 2019 · strength 0.10
  16. Mikael Hans Sodergren · 1 shared paper, 2019 · strength 0.10
  17. Yudong Qiu · 1 shared paper, 2018 · strength 0.09
  18. Shengping Li · 1 shared paper, 2018 · strength 0.09
  19. Yingtian Wei · 1 shared paper, 2021 · strength 0.08
  20. Chengli Li · 1 shared paper, 2021 · strength 0.08
  21. Tianan Jiang · 1 shared paper, 2021 · strength 0.08
  22. Yinying Lu · 1 shared paper, 2021 · strength 0.08
  23. Liwei Wang · 1 shared paper, 2021 · strength 0.08
  24. Ming Kuang · 1 shared paper, 2021 · strength 0.08
  25. Junhui Sun · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.